Tredje AP fonden trimmed its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 28.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 165,043 shares of the semiconductor company’s stock after selling 66,134 shares during the quarter. Tredje AP fonden owned 0.09% of Synopsys worth $81,431,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. Vanguard Group Inc. boosted its position in Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after buying an additional 3,120,401 shares during the period. Norges Bank bought a new stake in shares of Synopsys in the 2nd quarter valued at about $647,964,000. Ameriprise Financial Inc. boosted its holdings in Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after acquiring an additional 585,494 shares during the period. M&G PLC boosted its holdings in Synopsys by 86,263.0% during the 3rd quarter. M&G PLC now owns 567,405 shares of the semiconductor company’s stock valued at $279,731,000 after acquiring an additional 566,748 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in Synopsys by 177.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock worth $427,269,000 after acquiring an additional 553,924 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Insider Activity
In other news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by insiders.
Synopsys News Summary
- Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
- Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
- Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
- Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
- Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
- Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades
Synopsys Price Performance
SNPS opened at $439.94 on Friday. The stock has a fifty day simple moving average of $474.06 and a two-hundred day simple moving average of $483.92. The company has a market cap of $84.17 billion, a price-to-earnings ratio of 55.06, a price-to-earnings-growth ratio of 3.68 and a beta of 1.12. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the business earned $3.40 EPS. Synopsys’s quarterly revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several analysts have weighed in on SNPS shares. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research report on Friday. Morgan Stanley upped their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Piper Sandler lowered shares of Synopsys from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $602.00 to $520.00 in a report on Tuesday, January 13th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their price objective for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Needham & Company LLC raised their target price on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and an average price target of $547.00.
Check Out Our Latest Stock Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
